.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Express Scripts
UBS
Julphar
Baxter
Citi
US Army
Covington
QuintilesIMS

Generated: July 26, 2017

DrugPatentWatch Database Preview

ILOTYCIN Drug Profile

« Back to Dashboard

What is the patent landscape for Ilotycin, and what generic Ilotycin alternatives are available?

Ilotycin is a drug marketed by Dista and is included in three NDAs.

The generic ingredient in ILOTYCIN is erythromycin gluceptate. There are ninety-eight drug master file entries for this compound. Additional details are available on the erythromycin gluceptate profile page.

Summary for Tradename: ILOTYCIN

Patents:0
Applicants:1
NDAs:3
Bulk Api Vendors: see list42
Patent Applications: see list9,224
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ILOTYCIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dista
ILOTYCIN
erythromycin
TABLET, DELAYED RELEASE;ORAL061910-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Dista
ILOTYCIN GLUCEPTATE
erythromycin gluceptate
INJECTABLE;INJECTION050370-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Dista
ILOTYCIN
erythromycin
OINTMENT;OPHTHALMIC050368-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Dista
ILOTYCIN GLUCEPTATE
erythromycin gluceptate
INJECTABLE;INJECTION050370-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Dista
ILOTYCIN GLUCEPTATE
erythromycin gluceptate
INJECTABLE;INJECTION050370-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Merck
Medtronic
Moodys
QuintilesIMS
Chinese Patent Office
Deloitte
Cerilliant
Johnson and Johnson
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot